Richard A. Fair's most recent trade in Enliven Therapeutics Inc was a trade of 875,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Enliven Therapeutics Inc | Richard A. Fair | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2025 | 875,000 | 875,000 | - | - | Stock Option (right to buy) |